Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D K Stammers

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|February 22, 2000
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analysesJ Ren, J Diprose, J Warren, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Biaryl acids: novel non-nucleoside inhibitors of HIV reverse transcriptase types 1 and 2J Milton, M J Slater, A J Bird, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changesJ Ren, R M Esnouf, A L Hopkins, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitorsM Tisdale, B A Larder, D M Lowe, et al.
Journal of Molecular Biology|September 30, 1994
Crystals of HIV-1 reverse transcriptase diffracting to 2.2 A resolutionD K Stammers, D O Somers, C K Ross, et al.
Journal of Medicinal Chemistry|March 1, 1985
Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analoguesL F Kuyper, B Roth, D P Baccanari, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Allosteric inhibitors against HIV-1 reverse transcriptase: design and synthesis of MKC-442 analogues having an omega-functionalized acyclic structureH Tanaka, R T Walker, A L Hopkins, et al.
The Journal of Biological Chemistry|January 10, 1985
Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprimD A Matthews, J T Bolin, J M Burridge, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistanceB A Larder, S Bloor, S D Kemp, et al.
Journal of Medicinal Chemistry|April 12, 1996
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitorsA L Hopkins, J Ren, R M Esnouf, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|February 22, 2000
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analysesJ Ren, J Diprose, J Warren, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Biaryl acids: novel non-nucleoside inhibitors of HIV reverse transcriptase types 1 and 2J Milton, M J Slater, A J Bird, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1998
3'-Azido-3'-deoxythymidine drug resistance mutations in HIV-1 reverse transcriptase can induce long range conformational changesJ Ren, R M Esnouf, A L Hopkins, et al.
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Structural characterization of HIV reverse transcriptase: a target for the design of specific virus inhibitorsM Tisdale, B A Larder, D M Lowe, et al.
Journal of Molecular Biology|September 30, 1994
Crystals of HIV-1 reverse transcriptase diffracting to 2.2 A resolutionD K Stammers, D O Somers, C K Ross, et al.
Journal of Medicinal Chemistry|March 1, 1985
Receptor-based design of dihydrofolate reductase inhibitors: comparison of crystallographically determined enzyme binding with enzyme affinity in a series of carboxy-substituted trimethoprim analoguesL F Kuyper, B Roth, D P Baccanari, et al.
Antiviral Chemistry & Chemotherapy|January 6, 1999
Allosteric inhibitors against HIV-1 reverse transcriptase: design and synthesis of MKC-442 analogues having an omega-functionalized acyclic structureH Tanaka, R T Walker, A L Hopkins, et al.
The Journal of Biological Chemistry|January 10, 1985
Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprimD A Matthews, J T Bolin, J M Burridge, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistanceB A Larder, S Bloor, S D Kemp, et al.
Journal of Medicinal Chemistry|April 12, 1996
Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitorsA L Hopkins, J Ren, R M Esnouf, et al.
Pageof 7